Following the FDA's green light for a combo regimen of Sanofi’s Sarclisa in patients with newly diagnosed multiple myeloma ...
After a long road that included a three-month delay as the agency pushed for additional data, the US FDA has approved Sanofi ...
FDA Approves Sanofi’s Sarclisa in First-Line Multiple Myeloma The FDA granted approval for the expanded use of Sanofi’s ...